Ligand validation:6ASW

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ASW_GOL_B_502	61%	92%	0.177	0.968	0.37	0.18	-	-	1	0	100%	1
6ASW_GOL_B_503	59%	87%	0.185	0.969	0.31	0.38	-	-	0	0	100%	1
6ASW_GOL_D_504	43%	88%	0.212	0.937	0.36	0.3	-	-	0	0	100%	1
6ASW_GOL_B_505	40%	90%	0.239	0.952	0.36	0.24	-	-	3	0	100%	1
6ASW_GOL_B_501	38%	89%	0.244	0.949	0.38	0.27	-	-	1	0	100%	1
6ASW_GOL_B_504	30%	88%	0.243	0.906	0.41	0.27	-	-	0	0	100%	1
6ASW_GOL_D_501	27%	90%	0.234	0.879	0.36	0.24	-	-	0	0	100%	1
6ASW_GOL_B_506	25%	91%	0.275	0.915	0.4	0.16	-	-	3	0	100%	1
6ASW_GOL_D_502	23%	87%	0.3	0.926	0.35	0.35	-	-	0	0	100%	1
6ASW_GOL_B_507	11%	91%	0.283	0.797	0.36	0.23	-	-	1	0	100%	1
6ASW_GOL_D_503	3%	89%	0.431	0.767	0.36	0.28	-	-	1	0	100%	1
6ASW_GOL_C_604	1%	90%	0.515	0.729	0.36	0.26	-	-	0	0	100%	1
1R0A_GOL_P_3002	61%	0%	0.13	0.92	4.5	5.78	5	3	0	0	100%	1
6AVM_GOL_B_501	53%	91%	0.175	0.938	0.38	0.2	-	-	1	0	100%	1
8X21_GOL_D_502	52%	31%	0.192	0.952	1.45	1.32	1	1	0	0	100%	1
8X22_GOL_D_502	50%	90%	0.178	0.928	0.22	0.38	-	-	1	0	100%	1
6BSJ_GOL_A_603	42%	87%	0.142	0.861	0.33	0.36	-	-	1	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.